Rapamycin Holdings, Inc. Opens First Human Clinical Trial of its eRapa Compound Targeting Early Stage Prostate Cancer

  • Michael A Liss

Press/Media: Press / Media

PeriodSep 18 2018

Media coverage

1

Media coverage

  • TitleRapamycin Holdings, Inc. Opens First Human Clinical Trial of its eRapa Compound Targeting Early Stage Prostate Cancer
    Media name/outletIndia Pharma News
    CountryIndia
    Date9/18/18
    PersonsMichael A Liss